How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Micron Technology Inc. | €778.60 | €1,294.4 |
| Delta Air Lines Inc. | €75.24 | €72.62 |
| Aerovironment | €122.50 | €257.49 |
| Security | Price | Target price |
|---|---|---|
| Veganz Group AG | €2.73 | - |
| Jetblue Airways Corp. | €4.62 | €3.44 |
| Lennar Corp. A | €73.22 | €73.19 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Quantumcore Ltd. | AlexanderDanielSchneider | 19.32% |
| B Sivers Ima Holding Ab | AlexanderDanielSchneider | 17.95% |
| B Sivers Ima Holding Ab | Vassago1 | 16.35% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Veganz Group AG | blaugold | -34.17% |
| S Agenus Inc. | Wolf_of_WS | -23.64% |
| S Q32 Bio Inc. | thomasw | -14.77% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
A.D.S 4
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Uranium Energy Corp
WKN: A0JDRR / Name: Uranium Energy / Stock / Uranium / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Paypal Holdings Inc | €48.08 | 15.890% |
| Coty Inc | €2.16 | 9.640% |
| Under Armour Inc. A | €6.20 | 7.080% |
| Invesco Ltd. | €26.67 | 5.960% |
| Discovery Communications C | €22.42 | 5.110% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Pentair plc | €55.00 | -17.020% |
| Western Digital Corp. | €443.95 | -10.020% |
| NetApp Inc. | €137.60 | -9.980% |
| Micron Technology Inc. | €778.60 | -9.590% |
| Anthem Inc. | €341.00 | -9.480% |
Courses
sharewise Introduction
Key figures for stocks
Predictions
AngloGold Ashanti Ltd. ADR
17:45
15.07.27
09.10.23
Top News
2 Quantum Stocks That Could Challenge IonQ’s Leadership
Key Points
- Interested in Quantinuum Inc.? Here are five stocks we like better.
- IonQ shares have fallen about 35% in a month despite strong Q1 2026 results, with widening losses per share and a
Plot Twist: 12 States Could Stall the Paramount-Warner Bros. Discovery Mega-Merger
Key Points
- Interested in Warner Bros. Discovery, Inc.? Here are five stocks we like better.
- A 12-state antitrust lawsuit led by California threatens to delay the $110 billion merger of Paramount
First Horizon Q2 Earnings Call Highlights
Key Points
- Interested in First Horizon Corporation? Here are five stocks we like better.
- First Horizon posted stronger second-quarter results, with adjusted EPS up 20% year over year and loan
Equity Bancshares Q2 Earnings Call Highlights
Key Points
- Interested in Equity Bancshares, Inc.? Here are five stocks we like better.
- Equity Bancshares posted stronger core profitability in Q2 2026 as merger-related noise faded, with GAAP
Elevance Health Q2 Earnings Call Highlights
Key Points
- Interested in Elevance Health, Inc.? Here are five stocks we like better.
- Elevance Health raised its 2026 adjusted EPS outlook after Q2 results beat expectations, now guiding to at
U.S. IPO Market Has More Room to Rally in H2 2026: ETFs Poised to Win
The IPO market began 2026 on a solid footing, with robust activity in the first half setting the stage for continued momentum in the second half of the year. While investor demand for new listings
Producer Inflation Cools in June
Pre-market futures are gathering steam following this morning’s slew of economic data, which was quite encouraging overall. Wholesale inflation and another round of Q2 earnings results, along with a
Cybersecurity ETF (BUG) Hits New 52-Week High
For investors seeking momentum, Global X Cybersecurity ETF BUG is probably on the radar. The fund just hit a 52-week high and is up 82.25% from its 52-week low price of $23.15/share.
But are more
Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data
Shares of Biogen BIIB were down 8.2% yesterday after the company presented data from the phase II CELIA study evaluating its experimental tau-targeting Alzheimer’s disease (AD) drug, diranersen, at
J&J Q2 Earnings Beat on Darzalex, Tremfya Growth, 2026 Outlook Raised
Johnson & Johnson’s JNJ second-quarter 2026 earnings came in at $2.90 per share, which beat the Zacks Consensus Estimate of $2.84. Earnings rose 4.7% from the year-ago period.
Adjusted earnings
Alphabet’s AI Spending Question Looms Over Q2 Earnings
Key Points
- Interested in Alphabet Inc.? Here are five stocks we like better.
- Alphabet's Q2 2026 report, due July 22, is considered pivotal given the stock trades roughly 12% below its 52-week
News
3 Small-Cap Stocks Trading Under $10 With Room to Run
Key Points
- Interested in Aveanna Healthcare Holdings Inc.? Here are five stocks we like better.
- As mega-cap tech stumbles, analyst James Early recommends Aveanna Healthcare, Genworth Financial
Cameco Resolves Cigar Lake Disruption: Are 2026 Targets on Track?
Cameco Corporation CCJ has confirmed that operations at the Cigar Lake uranium mine and Orano’s McClean Lake mill have resumed and reinforced confidence in its 2026 output targets. The restart
TSLA Q2 Earnings Beat Likely: Why the Stock Still Isn't a Buy
Tesla TSLA is slated to release second-quarter 2026 results on July 22, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings and revenues is pegged at 47 cents
Should You Buy, Sell or Hold ABBV Stock After Its 9% YTD Rise?
AbbVie ABBV stock has risen 8.9% so far this year as investor confidence strengthened in the company's post-Humira growth strategy. Despite Humira's U.S. patent expiry in 2023, AbbVie has
Can Argan's Record Q1 Results Keep the Stock on Its Winning Path?
Argan, Inc. AGX has emerged as one of the strongest performers in the engineering and construction space, riding a wave of accelerating investments in power generation, industrial infrastructure and
Plumas Bancorp (PLBC) Beats Q2 Earnings and Revenue Estimates
Plumas Bancorp (PLBC) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.05 per share a year ago. These
Will Travelers Pull Off a Surprise This Earnings Season?
The Travelers Companies, Inc. TRV is expected to register a decline in its bottom line but an improvement in its top line when it reports second-quarter 2026 results on July 17, before the opening
Can Orion's Mission-Critical Projects Fuel Shareholder Gains?
Orion Group Holdings, Inc. ORN appears to be capitalizing on several long-term infrastructure trends that are reshaping the specialty construction industry. The company delivered a solid
Aehr Test Systems' Q4 Earnings Beat Estimates, Revenues Up Y/Y
Aehr Test Systems AEHR reported non-GAAP earnings of 11 cents per share for the fourth quarter of fiscal 2026, surpassing the Zacks Consensus Estimate by 1200%. The company had posted a loss of 1
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobieren
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.